Renaissance Technologies’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.81M | Sell |
410,048
-43,952
| -10% | -$408K | 0.01% | 1693 |
|
|
2025
Q1 | $3.33M | Buy |
+454,000
| New | +$3.33M | 0.01% | 1687 |
|
|
2024
Q2 | – | Sell |
-29,700
| Closed | -$270K | – | 3830 |
|
|
2024
Q1 | $270K | Buy |
+29,700
| New | +$270K | ﹤0.01% | 3127 |
|
|
2023
Q4 | – | Sell |
-125,200
| Closed | -$393K | – | 4010 |
|
|
2023
Q3 | $393K | Buy |
125,200
+100,307
| +403% | +$315K | ﹤0.01% | 2823 |
|
|
2023
Q2 | $128K | Sell |
24,893
-46,300
| -65% | -$238K | ﹤0.01% | 3413 |
|
|
2023
Q1 | $375K | Sell |
71,193
-222,800
| -76% | -$1.17M | ﹤0.01% | 3015 |
|
|
2022
Q4 | $826K | Buy |
293,993
+279,200
| +1,887% | +$784K | ﹤0.01% | 2646 |
|
|
2022
Q3 | $61K | Sell |
14,793
-366,707
| -96% | -$1.51M | ﹤0.01% | 3706 |
|
|
2022
Q2 | $1.53M | Sell |
381,500
-129,305
| -25% | -$520K | ﹤0.01% | 2386 |
|
|
2022
Q1 | $2.53M | Buy |
510,805
+430,705
| +538% | +$2.13M | ﹤0.01% | 2056 |
|
|
2021
Q4 | $558K | Sell |
80,100
-166,100
| -67% | -$1.16M | ﹤0.01% | 3023 |
|
|
2021
Q3 | $2.46M | Sell |
246,200
-80,922
| -25% | -$809K | ﹤0.01% | 1937 |
|
|
2021
Q2 | $4.64M | Buy |
327,122
+277,222
| +556% | +$3.93M | 0.01% | 1683 |
|
|
2021
Q1 | $819K | Sell |
49,900
-284,166
| -85% | -$4.66M | ﹤0.01% | 2697 |
|
|
2020
Q4 | $6.92M | Buy |
+334,066
| New | +$6.92M | 0.01% | 1395 |
|
|
2017
Q2 | – | Sell |
-88,900
| Closed | -$825K | – | 3317 |
|
|
2017
Q1 | $825K | Sell |
88,900
-56,200
| -39% | -$522K | ﹤0.01% | 2607 |
|
|
2016
Q4 | $1.21M | Buy |
+145,100
| New | +$1.21M | ﹤0.01% | 2464 |
|
|
2016
Q3 | – | Sell |
-47,300
| Closed | -$234K | – | 3451 |
|
|
2016
Q2 | $234K | Buy |
+47,300
| New | +$234K | ﹤0.01% | 3005 |
|
|
2015
Q3 | – | Sell |
-10,992
| Closed | -$231K | – | 3299 |
|
|
2015
Q2 | $231K | Buy |
+10,992
| New | +$231K | ﹤0.01% | 2950 |
|